ArticleCommunications biology2020

A combined computational and experimental strategy identifies mutations conferring resistance to drugs targeting the BCR-ABL fusion protein.

Jinxin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.